CH Des pays de Morlaix
Morlaix, 29600, France
NCT Number: NCT02873780
The aim of this study is to compare oxygen desaturation during two tests: the 6 minute walk test and the 3 minute step test, for COPD patients.
Looking for future studies?
Notify Me40 year–90 year
All sexes
Observational
Morlaix, 29600, France
The 6 minute walk test (6MWT) is the best field test to determine oxygen desaturation during effort, in COPD patients. However, the test need a 30m corridor.
The 3 minute step test (3MST) is a other field test used in COPD patients. But no study shows that 3MST can be used to determine oxygen desaturation.
The aim of this study is to compare oxygen desaturation during these to tests : the 6MWT and the 3MST.
50 patients will be included in this study.
Patients realize two 6MWT and two 3MST, with rest between each test.
Oxygen saturation, heart rate are registered during the tests, dyspnea, leg peniblility are notified before and after each test, distance or number of steps are noted.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 3 minutes
oxygen saturation is compared between 6MWT and 3MST at the end of the 2 tests
Time frame: 3 minutes
heart rate is compared between 6MWT and 3MST at the end of the 2 tests
Time frame: 3 minutes
dyspnea (Borg Scale) is compared between 6MWT and 3MST at the end of the 2 tests
Time frame: 3 minutes
leg penibility (Borg Scale) is compared between 6MWT and 3MST at the end of the 2 tests
Centre Hospitalier des Pays de Morlaix
Other
Comparison of 3-Minute Step Test (3MStepT) and 6-Minute Walk Test (6MWT) in Chronic Obstructive Pulmonary Disease Patients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05572333
COPD, Chronic Disease
Frankfurt, Germany
View Trial DetailsNCT05516316
COPD, Chronic Disease
Hanover, Germany
View Trial DetailsNCT02760329
Asthma, Bronchial Diseases
Loma Linda, California, United States
View Trial DetailsNCT06474858
Body Weight, COPD
Arnhem, Netherlands
View Trial Details